You are here

  • Home
  • Archive
  • Volume 23, Issue 3
  • Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Article info

Article menu
Download PDFPDF
Chemotherapy
Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Authors

  1. Address correspondence and reprint requests to Bram H. Goldstein, PhD, Gynecologic Oncology Associates, 351 Hospital Rd, Suite 507, Newport Beach, CA. E-mail: bram{at}gynoncology.com.

Citation

Mendivil AA, Micha JP, Brown JV, et al
Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
International Journal of Gynecologic Cancer 2013;23:533-539.

Publication history

  • Received August 22, 2012
  • Accepted December 30, 2012
  • First published March 1, 2013.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2013 by IGCS and ESGO